Healios K.K. (OTCMKTS:HLOSF) Sees Large Decline in Short Interest

Healios K.K. (OTCMKTS:HLOSF) was the target of a significant drop in short interest in November. As of November 30th, there was short interest totalling 500 shares, a drop of 89.6% from the November 15th total of 4,800 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is currently 1.0 days.

Healios K.K. Price Performance

Shares of Healios K.K. stock remained flat at 1.35 on Wednesday. Healios K.K. has a 12-month low of 0.93 and a 12-month high of 1.73. The stock’s 50 day moving average price is 1.46 and its two-hundred day moving average price is 1.36.

Healios K.K. Company Profile

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.